Use of ERbeta-selective ligands for regulating fertility and compounds useful therefor
申请人:SCHERING AKTIENGESELLSCHAFT
公开号:US20030083377A1
公开(公告)日:2003-05-01
The present invention discloses the use of ER&bgr;-selective ligands for production of medicaments for regulating fertility without additional use of a progestin.
ER&bgr;-agonists are used for treatment of infertility and ER&bgr;-antagonists for contraception.